Clinical trial
A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
NCT00931346 is registered in ClinicalTrials.gov with International AIDS Vaccine Initiative as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
- Lead sponsor
- International AIDS Vaccine Initiative
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- October 31, 2010
- Enrollment
- 72 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection